This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1993 Jul 1;119(1):91-2.

doi: 10.7326/0003-4819-119-1-199307010-00017.

Predicting response to recombinant human erythropoietin

M Mittelman, S Floru

PMID: 8338597
DOI: 10.7326/0003-4819-119-1-199307010-00017

Comment

Predicting response to recombinant human erythropoietin

M Mittelman et al. Ann Intern Med. 1993.

. 1993 Jul 1;119(1):91-2.

doi: 10.7326/0003-4819-119-1-199307010-00017.

Authors

M Mittelman, S Floru

PMID: 8338597
DOI: 10.7326/0003-4819-119-1-199307010-00017

No abstract available

PubMed Disclaimer

Comment on

Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials.
Henry DH, Beall GN, Benson CA, Carey J, Cone LA, Eron LJ, Fiala M, Fischl MA, Gabin SJ, Gottlieb MS, et al. Henry DH, et al. Ann Intern Med. 1992 Nov 1;117(9):739-48. doi: 10.7326/0003-4819-117-9-739. Ann Intern Med. 1992. PMID: 1416576 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information